Immunovaccine to Present New Pre-clinical Combination Therapy Data at the AACR Annual Meeting
24 mars 2017 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - March 24, 2017) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that new pre-clinical data on...
Immunovaccine's Lead Immuno-Oncology Candidate to Enter Investigator-Sponsored Phase 2 Clinical Trial in Ovarian Cancer in Combination With Approved Anti-PD-1 Drug
06 févr. 2017 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Feb. 6, 2017) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that the UHN's Princess...
Immunovaccine Appoints Seasoned Financial Executive Pierre Labbe as CFO
03 févr. 2017 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Feb. 3, 2017) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine to Present at 2017 BIO CEO & Investor Conference
02 févr. 2017 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Feb. 2, 2017) - Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...
Immunovaccine to Present at 2017 Biotech Showcase Conference
04 janv. 2017 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 4, 2017) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...
Immunovaccine Announces Closing of $8 Million Bought Deal Private Placement Financing
09 déc. 2016 09h23 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Dec. 9, 2016) -
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES
Immunovaccine Inc....
Immunovaccine Inc. ("IMV-T") - $8 Million Bought Deal Private Placement Financing
23 nov. 2016 17h09 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 23, 2016) -
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF...
The European Medicines Agency Grants Orphan Drug Designation Status to Immunovaccine's DPX-Survivac in Ovarian Cancer
22 nov. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 22, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine to Present at 2016 Biotech & Money Showcase Conference
14 nov. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 14, 2016) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...
Immunovaccine Announces Third Quarter 2016 Financial Results and Provides Corporate Update
08 nov. 2016 17h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 8, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical-stage vaccine and immunotherapy company,...